Skip to main content

Launch of User-Friendly Hematology Analyzers is the Best Way to Venture into the Market

The global hematology testing is perceived to be a market with high attractiveness, by the investors. Strong investments in this field aided by considerable research activities by both public and private sectors are expected to propel the growth of the market in the years that follow. In spite of having several favorable factors, investments into the market are being hindered by the slow adoption rate of expensive hematology testing devices in low income and middle-come countries of the world. The most promising way to venture into this market and gain measurable profits is through innovations and development of advanced, compact, accurate, and user-friendly hematology analyzers.

Sysmex Corporation, headquartered in Japan is catering to in-vitro diagnostics, offers wide range of hematology testing products ranging from hematology analyzers and flow cytometers to reagents, stains, controls, and calibrators. The huge product contribution of the company resulted in its market dominance in 2017 and 2018, with an overall good amount of the global market share in 2017 and 34.73% of the global market share in 2018. Following Sysmex Corporation, Abbott Laboratories was the second major contributor of the global market revenue, accounting for good rate of the total market share in 2017 and 2018, respectively.

Next to North America, Europe is the second leading contributor of the global hematology testing market. Increasing research and investments pertaining to the development technologically advanced hematology testing products coupled with significant support from both public and private sectors in terms of funding are the key driving factors for the growth of the hematology testing in Europe. Europe contributed to 23.00% of the market share in 2018. Within Europe, Germany is the leading country and Italy is expected to witness the highest CAGR during the forecast period between 2019 and 2029.



The global hematology testing market, by end user, is concentrated around hospitals, clinical testing laboratories, research institutions, and patient self-testing, among others. With the growing prevalence of blood-related disorders across the world, the need to develop advanced hematology tests is growing rapidly leading to vast technological advancement in the field of hematology.
Labels:

Comments

  1. Blog279995 March 2020 at 18:14

    According to Stanford Medical, It's indeed the one and ONLY reason women in this country get to live 10 years longer and weigh 42 pounds less than we do.

    (By the way, it really has NOTHING to do with genetics or some secret diet and EVERYTHING around "HOW" they eat.)

    P.S, I said "HOW", and not "what"...

    TAP this link to determine if this quick quiz can help you unlock your true weight loss possibility

    ReplyDelete

Post a Comment

Popular posts from this blog

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

  Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...
Post a Comment
Read more

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

ADAS and Autonomous Driving Component Market

As per the recent BIS Research report, the ADAS and autonomous driving component market is segmented into component type, level of autonomy, vehicle type, and region for the purpose of study. These segments are further sub-segmented into various categories. In case of market by component type, it is sub-segmented into camera, radar, ultrasonic sensors, LiDAR, and ECU. The use of LiDAR is increasing rapidly in the market owing to reducing cost of LiDAR sensors and their greater range.
Post a Comment
Read more